The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 08, 2020

Filed:

May. 05, 2016
Applicant:

University of Louisville Research Foundation, Inc., Louisville, KY (US);

Inventors:

Mohammad Tariq Malik, Prospect, KY (US);

Martin G. O'Toole, Louisville, KY (US);

Paula J. Bates, Louisville, KY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); A61K 47/69 (2017.01); A61K 41/00 (2020.01); A61K 49/04 (2006.01); A61K 31/28 (2006.01); A61K 45/06 (2006.01); A61K 31/7105 (2006.01); A61K 49/18 (2006.01); A61K 9/00 (2006.01); A61K 47/54 (2017.01); A61P 35/00 (2006.01); C07K 16/18 (2006.01); C07K 16/30 (2006.01); C12N 15/115 (2010.01);
U.S. Cl.
CPC ...
A61K 47/6923 (2017.08); A61K 9/0019 (2013.01); A61K 31/28 (2013.01); A61K 31/7105 (2013.01); A61K 41/0038 (2013.01); A61K 45/06 (2013.01); A61K 47/549 (2017.08); A61K 47/6929 (2017.08); A61K 49/0032 (2013.01); A61K 49/0065 (2013.01); A61K 49/0428 (2013.01); A61K 49/1875 (2013.01); A61K 49/1881 (2013.01); A61P 35/00 (2018.01); C07K 16/18 (2013.01); C07K 16/30 (2013.01); C12N 15/115 (2013.01);
Abstract

A composition comprises an anti-nucleolin agent conjugated to nanoparticles, and optionally containing gadolinium. Furthermore, a pharmaceutical composition for treating cancer comprises a composition including an anti-nucleolin agent conjugated to nanoparticles, and a pharmaceutically acceptable carrier. The composition enhances the effectiveness of radiation therapy, enhancing contrast in X-ray imaging techniques, and when gadolinium is present, provide cancer selective MRI contrast agents.


Find Patent Forward Citations

Loading…